Muscle from an aged *mdx* mouse (left) contains large collagen deposits (red), but these are reduced when miR-21 is inhibited (right).Ardite et al. describe how increased production of a microRNA leads to progressive muscle deterioration in Duchenne muscular dystrophy (DMD) patients.

As DMD patients age, their damaged muscle cells are gradually replaced by collagen-rich fibrous tissue. This muscle fibrosis is partly induced by TGF-β, which is highly activated in DMD patients, though exactly how this cytokine promotes fibrogenesis is unclear. Ardite et al. examined the role of miR-21, a microRNA whose production is stimulated by TGF-β signaling.

miR-21 was upregulated in the collagen-producing fibroblasts of both DMD patients and muscular dystrophy model (*mdx*) mice. Inhibiting miR-21 reduced collagen levels and prevented, or even reversed, fibrogenesis in diseased animals, whereas *mdx* mice overexpressing the microRNA produced more collagen and developed fibrotic muscles at earlier ages.

Ardite et al. also discovered that TGF-β activity and miR-21 production were regulated by the balance of two extracellular factors: uPA---a protease that activates TGF-β---and its inhibitor PAI-1. *mdx* mice developed fibrotic muscles more quickly in the absence of PAI-1, but these symptoms could be reversed by inhibiting uPA with a drug or a specific siRNA. In addition to producing more collagen, PAI-1--null fibroblasts also proliferated rapidly because the extra miR-21 induced by active TGF-β inhibited the tumor-suppressive phosphatase PTEN.

TGF-β inhibitors prevent muscle fibrosis but have damaging side effects; this study suggests that uPA or miR-21 may make attractive alternative targets. Senior author Pura Muñoz-Cánoves now wants to investigate the function of miR-21 in other cell types that influence muscle homeostasis, such as the macrophages involved in tissue repair.
